about
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development.miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells.Inhibition of Cancer Cell Proliferation and Antiradical Effects of Decoction, Hydroalcoholic Extract, and Principal Constituents of Hemidesmus indicus R. Br.Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs.Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproductsNew uracil dimers showing erythroid differentiation inducing activities.Cytotoxic activity of C-geranyl compounds from Paulownia tomentosa fruits.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.trans-Resveratrol in Nutraceuticals: Issues in Retail Quality and Effectiveness
P50
Q35301892-6A3ECC5A-FB11-4C12-B80E-0AB0AFD8D643Q36611332-1DB3688E-602A-4C42-9A4F-CEEBCFFCEB8BQ37921863-5BA31E84-4D5A-44DF-B720-53188E43F9BCQ37962609-B3372B4E-C4A6-4426-9C97-A270E54F73B6Q38321556-E6F2C96D-A49D-439E-8891-BE82B63A121DQ38901968-849E49D7-D56C-495D-B977-13D960BF7585Q39018554-DF58FE14-27FE-4D8B-B03B-DA7EF18AF95AQ39069391-77B8E27C-B0F0-4F71-A37E-A219197C3BADQ39353313-D214301B-3EAB-4025-9FAA-90C8B1D116A2Q39388051-262328CD-5198-4B93-BC06-FE05B7633D3FQ39455677-B7890914-DA30-4EC5-979B-84ABB5865998Q39465808-EEB5811C-BD7A-47B6-9C23-4872681261C9Q39814424-FFEF2E3F-FA2F-48BA-9B20-4D0F0752F74AQ39906715-CCB8B281-3E53-421F-AD8A-D52F5FCB8A58Q39946900-5D6C5B3F-3CFA-4282-8B5A-5A7128F37543Q42224585-4AB21DB3-7A2C-4DFC-B025-060FCB00667AQ59364375-54931CAE-ABA0-4DA1-BB0C-86AC656A8297
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eleonora Brognara
@ast
Eleonora Brognara
@en
Eleonora Brognara
@es
Eleonora Brognara
@nl
type
label
Eleonora Brognara
@ast
Eleonora Brognara
@en
Eleonora Brognara
@es
Eleonora Brognara
@nl
prefLabel
Eleonora Brognara
@ast
Eleonora Brognara
@en
Eleonora Brognara
@es
Eleonora Brognara
@nl
P106
P1153
25521210500
P31
P496
0000-0002-7845-5895